Gene Green actually said...
Broadening off-label communications could erode FDA's approval standard as it would enable the uses of products never found to be safe or effective in patients and weaken consumer confidence in the FDA approval process.
Context
Gene Green argues that off-label communications could undermine FDA standards and consumer trust.
07/11/2017